These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29397747)

  • 1. Hyaluronic Acid-Modified Micelles Encapsulating Gem-C
    Liu X; Li W; Chen T; Yang Q; Huang T; Fu Y; Gong T; Zhang Z
    Mol Pharm; 2018 Mar; 15(3):1203-1214. PubMed ID: 29397747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
    Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
    Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells.
    Krishnamurthy S; Ng VW; Gao S; Tan MH; Hedrick JL; Yang YY
    Nanomedicine (Lond); 2015; 10(18):2819-32. PubMed ID: 26377155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
    Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
    Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
    Lu Z; Su J; Li Z; Zhan Y; Ye D
    Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
    Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
    Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
    Dalla Pozza E; Lerda C; Costanzo C; Donadelli M; Dando I; Zoratti E; Scupoli MT; Beghelli S; Scarpa A; Fattal E; Arpicco S; Palmieri M
    Biochim Biophys Acta; 2013 May; 1828(5):1396-404. PubMed ID: 23384419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
    Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
    Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
    Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
    Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer.
    Vogus DR; Evans MA; Pusuluri A; Barajas A; Zhang M; Krishnan V; Nowak M; Menegatti S; Helgeson ME; Squires TM; Mitragotri S
    J Control Release; 2017 Dec; 267():191-202. PubMed ID: 28823957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
    Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
    Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
    Godugu C; Doddapaneni R; Singh M
    Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.